Positiveid Corp. (PSID) 0.0780 $PSID
PositiveID Corporation Signs Space Act Agreement With NASA
GlobeNewswire - Mon May 05, 8:41AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB
SID), a developer of biological detection and diagnostics solutions, announced today that it has signed a Space Act Agreement with NASA's Ames Research Center to collaborate on testing the Company's Firefly Dx detection system ("Firefly" as a platform for biological research and commercial development for ground and space applications.
PositiveID's New President Lyle L. Probst Interviewed by SmallCapVoice.com About Company's Latest Contract
GlobeNewswire - Tue Apr 29, 7:08AM CDT
SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation ("PositiveID" or the "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, is now available. The interview can be heard at http://smallcapvoice.com/blog/4-25-14-smallca...ation-psid.
PositiveID announces up to USD4bn defence order to combat weapons of mass destruction
M2 - Fri Apr 25, 5:47AM CDT
Diagnostics solutions company PositiveID (Other OTC SID) reported on Thursday the receipt of a defence agreement to conduct research and development to combat weapons of mass destruction.
PositiveID Corporation Teaming Partner Leidos Awarded Defense Threat Reduction Agency Contract Valued at Up to $4 Billion
GlobeNewswire - Thu Apr 24, 7:30AM CDT
PositiveID Corporation ("PositiveID" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its teaming partner Leidos (f/k/a/ Science Applications International Corporation) was awarded a prime contract by the U.S. Defense Threat Reduction Agency ("DTRA" to conduct research and development to combat weapons of mass destruction. The multiple-award indefinite delivery/indefinite quantity ("ID/IQ" contract has a five-year base period of performance, a five year option, and a total value of approximately $4 billion for all awardees, if all options are exercised. The contract was awarded under the Combating Weapons of Mass Destruction Research and Technology Development ID/IQ contract.
PositiveID Corporation Appoints Lyle L. Probst President
GlobeNewswire - Mon Apr 21, 7:39AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it has appointed Lyle L. Probst President of the Company. Mr. Probst, who has 15 years of managerial experience with large bio-detection programs and products, joined PositiveID in 2011 at the time that PositiveID acquired Microfluidic Systems, based in Pleasanton, CA.
In a New Audio Interview at SmallCapVoice.com, PositiveID Corporation Discusses New Contract for Its M-BAND System
GlobeNewswire - Mon Apr 07, 9:23AM CDT
SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation ("PositiveID" or the "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, is now available. The interview can be heard at http://smallcapvoice.com/blog/4-3-14-smallcap...ation-psid
Limitless Venture Group's Stock Volume Soars On News of Hemp-Based Products
ACCESSWIRE - Wed Apr 02, 8:41AM CDT
Limitless Venture Group Inc.'s (OTCPINK: LVGI) stock volume skyrocketed Apr. 1, with 292,012,825 shares changing hands, nearly three times more than its three-month average volume of 107,767,353 shares.
The Market and Potential for Molecular Point of Care Diagnostics Report Provides Market Estimates up to 2018
M2 - Mon Mar 31, 11:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gb6tbz/the_market_and) has announced the addition of the "The Market and Potential for Molecular Point of Care Diagnostics" report to their offering. The molecular diagnostic market and the point-of-care (POC) testing markets are two of the fastest growing segments of the overall IVD market. Historically, these have been completely different market segments. Not anymore. There has been a growing interest in developing molecular diagnostic platforms that can be used in POC settings. Indeed, as this new market research report details, the emerging area of rapid molecular POC testing has attracted over $650 million in investments and financings over the past five years (2009 to 2013). The Market and Potential for Molecular Point of Care Diagnostics, offers a quantitative assessment of the molecular diagnostic market, and of the point-of-care (POC) testing market, and then looks at the emerging field of molecular diagnostic POC testing. Many companies are developing molecular diagnostic platforms and assays that are designed to for near-patient or POC testing, and the earliest of these systems are starting to reach the market. The initial market focus for most of these companies is on infectious disease testing, where rapid test results generate important actionable information that physicians can use to make treatment decisions. Over 75 companies involved in this market are profiled in this report. As expected with any group of start-up companies, many are struggling or are surviving on limited financial resources. However, some new companies that are focusing on molecular diagnostic POC testing have received significant investments. Some of the Companies Mentioned: - Abacus Diagnostica Oy - bioMerieux sa - Canon U.S. Life Sciences - DiaSorin S.p.A. - Espira, Inc. - Focus Diagnostics, Inc. - GenePOC Inc. - Instrumentation Laboratory - Lumora Ltd - Meridian Bioscience, Inc. - NetBio, Inc. - OptiGene Ltd. - PositiveID Corporation - QIAGEN N.V - Spartan Bioscience Inc. - Veredus Laboratories - Wave 80 Biosciences - Xagenic Inc. For more information visit http://www.researchandmarkets.com/research/gb...market_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
PositiveID Signs Agreement With Unit of UTC Aerospace Systems for U.S. Government Contract
GlobeNewswire - Mon Mar 31, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, is proud to announce that it has signed a contract with UTC Aerospace Systems' ISR & Space Systems unit to support a contract for the U.S. Department of Defense ("DoD" . This contract is expected to be performed over the next seven months, between March and September, 2014.
PositiveID Corporation's CEO to Present at InvestorIdeas.com Security and Defense Conference on March 11, 2014 in New York City
GlobeNewswire - Wed Mar 05, 7:42AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the InvestorIdeas.com Security and Defense Conference at 3:30 pm on March 11, 2014, at the New York Hilton Midtown in New York City. The Company's presentation will be posted in the Investors & Media section of its website under Events & Presentations.
PositiveID Corporation Provides 2013 Review and 2014 Outlook
GlobeNewswire - Wed Feb 26, 7:42AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological threat detection and diagnostics solutions, today provided a review of its 2013 accomplishments and its outlook for 2014.
PositiveID Corporation to Present at the National Investment Banking Association Conference on February 27-28, 2014
GlobeNewswire - Thu Feb 13, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the National Investment Banking Association ("NIBA" Conference on February 27-28, 2014, at the Riverside Hotel in Fort Lauderdale, FL. The Company's presentation will be posted in the Investors & Media section of its website.
Cerus (CERS) Soars: Stock Adds 6.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 8:39AM CST
Cerus Corporation was a big mover last session, as its shares rose nearly 7% on the day.
OraSure Technologies (OSUR) Jumps: Stock Up 10.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 7:51AM CST
OraSure Technologies, Inc. was a big mover last session, as its shares rose over 10% on the day.
GW Pharmaceuticals plc (GWPH) Jumps: Stock Rises 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 05, 8:18AM CST
GW Pharmaceuticals plc (GWPH) was a big mover last session, as the company saw its shares rise by roughly 8% on the day.
PositiveID Corporation Adds U.S. Homeland Security and Counter-Terrorism Expert Thomas DiNanno to Its Advisory Board
GlobeNewswire - Tue Feb 04, 9:48PM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced it has added Thomas DiNanno to its Advisory Board. Mr. DiNanno, who led the stand-up of the first National Bio-surveillance Integration System, joins PositiveID's current advisors Mike Campbell, Yuval Rabin and Dr. Kimothy Smith. The Company expects to leverage Mr. DiNanno's homeland security and counter-terrorism expertise and relationships within the U.S. government and private sector to secure opportunities for PositiveID's M-BAND and Firefly products.
PositiveID Featured in Government Security News and Homeland Security Today
GlobeNewswire - Tue Jan 28, 7:31AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its homeland security and medical diagnostics products, M-BAND and Firefly, are featured in Government Security News and Homeland Security Today.
PositiveID Publishes Report on Its BioThreat Detection and Diagnostics Solutions
GlobeNewswire - Thu Jan 23, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has published a report on the current market opportunities for its homeland security and medical diagnostics technologies.
PositiveID Corporation Appoints Michael Campbell to Its Advisory Board
GlobeNewswire - Tue Jan 14, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced it has appointed Michael Campbell to its Advisory Board. The Company plans to utilize Campbell's expertise and relationships to help it pursue strategic opportunities for its M-BAND and Firefly products within federal government agencies, state and local governments, and commercial enterprises. Campbell joins PositiveID's current advisors, Yuval Rabin and Dr. Kimothy Smith.
PositiveID Engages American Capital Ventures for Investor Relations Services
GlobeNewswire - Tue Jan 07, 7:31AM CST
PositiveID Corporation ("PositiveID" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has engaged American Capital Ventures, a boutique provider of comprehensive investor relations, financial marketing and capital advisory services to the micro- and small-cap community.
PositiveID Corporation Signs Space Act Agreement With NASA
GlobeNewswire - Mon May 05, 8:41AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it has signed a Space Act Agreement with NASA's Ames Research Center to collaborate on testing the Company's Firefly Dx detection system ("Firefly" as a platform for biological research and commercial development for ground and space applications. PositiveID's New President Lyle L. Probst Interviewed by SmallCapVoice.com About Company's Latest Contract
GlobeNewswire - Tue Apr 29, 7:08AM CDT
SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation ("PositiveID" or the "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, is now available. The interview can be heard at http://smallcapvoice.com/blog/4-25-14-smallca...ation-psid. PositiveID announces up to USD4bn defence order to combat weapons of mass destruction
M2 - Fri Apr 25, 5:47AM CDT
Diagnostics solutions company PositiveID (Other OTC
SID) reported on Thursday the receipt of a defence agreement to conduct research and development to combat weapons of mass destruction. PositiveID Corporation Teaming Partner Leidos Awarded Defense Threat Reduction Agency Contract Valued at Up to $4 Billion
GlobeNewswire - Thu Apr 24, 7:30AM CDT
PositiveID Corporation ("PositiveID"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its teaming partner Leidos (f/k/a/ Science Applications International Corporation) was awarded a prime contract by the U.S. Defense Threat Reduction Agency ("DTRA" to conduct research and development to combat weapons of mass destruction. The multiple-award indefinite delivery/indefinite quantity ("ID/IQ" contract has a five-year base period of performance, a five year option, and a total value of approximately $4 billion for all awardees, if all options are exercised. The contract was awarded under the Combating Weapons of Mass Destruction Research and Technology Development ID/IQ contract. PositiveID Corporation Appoints Lyle L. Probst President
GlobeNewswire - Mon Apr 21, 7:39AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it has appointed Lyle L. Probst President of the Company. Mr. Probst, who has 15 years of managerial experience with large bio-detection programs and products, joined PositiveID in 2011 at the time that PositiveID acquired Microfluidic Systems, based in Pleasanton, CA. In a New Audio Interview at SmallCapVoice.com, PositiveID Corporation Discusses New Contract for Its M-BAND System
GlobeNewswire - Mon Apr 07, 9:23AM CDT
SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation ("PositiveID" or the "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, is now available. The interview can be heard at http://smallcapvoice.com/blog/4-3-14-smallcap...ation-psid Limitless Venture Group's Stock Volume Soars On News of Hemp-Based Products
ACCESSWIRE - Wed Apr 02, 8:41AM CDT
Limitless Venture Group Inc.'s (OTCPINK: LVGI) stock volume skyrocketed Apr. 1, with 292,012,825 shares changing hands, nearly three times more than its three-month average volume of 107,767,353 shares.
The Market and Potential for Molecular Point of Care Diagnostics Report Provides Market Estimates up to 2018
M2 - Mon Mar 31, 11:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gb6tbz/the_market_and) has announced the addition of the "The Market and Potential for Molecular Point of Care Diagnostics" report to their offering. The molecular diagnostic market and the point-of-care (POC) testing markets are two of the fastest growing segments of the overall IVD market. Historically, these have been completely different market segments. Not anymore. There has been a growing interest in developing molecular diagnostic platforms that can be used in POC settings. Indeed, as this new market research report details, the emerging area of rapid molecular POC testing has attracted over $650 million in investments and financings over the past five years (2009 to 2013). The Market and Potential for Molecular Point of Care Diagnostics, offers a quantitative assessment of the molecular diagnostic market, and of the point-of-care (POC) testing market, and then looks at the emerging field of molecular diagnostic POC testing. Many companies are developing molecular diagnostic platforms and assays that are designed to for near-patient or POC testing, and the earliest of these systems are starting to reach the market. The initial market focus for most of these companies is on infectious disease testing, where rapid test results generate important actionable information that physicians can use to make treatment decisions. Over 75 companies involved in this market are profiled in this report. As expected with any group of start-up companies, many are struggling or are surviving on limited financial resources. However, some new companies that are focusing on molecular diagnostic POC testing have received significant investments. Some of the Companies Mentioned: - Abacus Diagnostica Oy - bioMerieux sa - Canon U.S. Life Sciences - DiaSorin S.p.A. - Espira, Inc. - Focus Diagnostics, Inc. - GenePOC Inc. - Instrumentation Laboratory - Lumora Ltd - Meridian Bioscience, Inc. - NetBio, Inc. - OptiGene Ltd. - PositiveID Corporation - QIAGEN N.V - Spartan Bioscience Inc. - Veredus Laboratories - Wave 80 Biosciences - Xagenic Inc. For more information visit http://www.researchandmarkets.com/research/gb...market_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
PositiveID Signs Agreement With Unit of UTC Aerospace Systems for U.S. Government Contract
GlobeNewswire - Mon Mar 31, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, is proud to announce that it has signed a contract with UTC Aerospace Systems' ISR & Space Systems unit to support a contract for the U.S. Department of Defense ("DoD" . This contract is expected to be performed over the next seven months, between March and September, 2014. PositiveID Corporation's CEO to Present at InvestorIdeas.com Security and Defense Conference on March 11, 2014 in New York City
GlobeNewswire - Wed Mar 05, 7:42AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the InvestorIdeas.com Security and Defense Conference at 3:30 pm on March 11, 2014, at the New York Hilton Midtown in New York City. The Company's presentation will be posted in the Investors & Media section of its website under Events & Presentations. PositiveID Corporation Provides 2013 Review and 2014 Outlook
GlobeNewswire - Wed Feb 26, 7:42AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological threat detection and diagnostics solutions, today provided a review of its 2013 accomplishments and its outlook for 2014. PositiveID Corporation to Present at the National Investment Banking Association Conference on February 27-28, 2014
GlobeNewswire - Thu Feb 13, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the National Investment Banking Association ("NIBA" Conference on February 27-28, 2014, at the Riverside Hotel in Fort Lauderdale, FL. The Company's presentation will be posted in the Investors & Media section of its website. Cerus (CERS) Soars: Stock Adds 6.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 8:39AM CST
Cerus Corporation was a big mover last session, as its shares rose nearly 7% on the day.
OraSure Technologies (OSUR) Jumps: Stock Up 10.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 7:51AM CST
OraSure Technologies, Inc. was a big mover last session, as its shares rose over 10% on the day.
GW Pharmaceuticals plc (GWPH) Jumps: Stock Rises 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 05, 8:18AM CST
GW Pharmaceuticals plc (GWPH) was a big mover last session, as the company saw its shares rise by roughly 8% on the day.
PositiveID Corporation Adds U.S. Homeland Security and Counter-Terrorism Expert Thomas DiNanno to Its Advisory Board
GlobeNewswire - Tue Feb 04, 9:48PM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced it has added Thomas DiNanno to its Advisory Board. Mr. DiNanno, who led the stand-up of the first National Bio-surveillance Integration System, joins PositiveID's current advisors Mike Campbell, Yuval Rabin and Dr. Kimothy Smith. The Company expects to leverage Mr. DiNanno's homeland security and counter-terrorism expertise and relationships within the U.S. government and private sector to secure opportunities for PositiveID's M-BAND and Firefly products. PositiveID Featured in Government Security News and Homeland Security Today
GlobeNewswire - Tue Jan 28, 7:31AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its homeland security and medical diagnostics products, M-BAND and Firefly, are featured in Government Security News and Homeland Security Today. PositiveID Publishes Report on Its BioThreat Detection and Diagnostics Solutions
GlobeNewswire - Thu Jan 23, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has published a report on the current market opportunities for its homeland security and medical diagnostics technologies. PositiveID Corporation Appoints Michael Campbell to Its Advisory Board
GlobeNewswire - Tue Jan 14, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced it has appointed Michael Campbell to its Advisory Board. The Company plans to utilize Campbell's expertise and relationships to help it pursue strategic opportunities for its M-BAND and Firefly products within federal government agencies, state and local governments, and commercial enterprises. Campbell joins PositiveID's current advisors, Yuval Rabin and Dr. Kimothy Smith. PositiveID Engages American Capital Ventures for Investor Relations Services
GlobeNewswire - Tue Jan 07, 7:31AM CST
PositiveID Corporation ("PositiveID"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has engaged American Capital Ventures, a boutique provider of comprehensive investor relations, financial marketing and capital advisory services to the micro- and small-cap community. 
